ESR1 and neoplasm: In contrast, when transferred into the nucleus, 4ICD can work as a co-activator of the estrogen receptor and - in the presence of exogenous estrogen - contribute to enhanced (tumor) cell growth [32] and thereby possibly account for an unfavorable disease course [37, 38].